ENTA icon

Enanta Pharmaceuticals

151 hedge funds and large institutions have $827M invested in Enanta Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 60 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

13% less capital invested

Capital invested by funds: $956M → $827M (-$129M)

23% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 60

73% less call options, than puts

Call options by funds: $897K | Put options by funds: $3.29M

Holders
151
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$897K
Puts
$3.29M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$162M
2
$88M
3
$87.8M
4
$81.7M
5
$46.4M
6
$41.4M
7
$35.1M
8
$28.6M
9
$28.4M
10
$16.2M
11
$14.5M
12
$12.4M
13
$11.4M
14
$11.1M
15
$8.8M
16
$7.84M
17
$7.76M
18
$7.76M
19
$6.31M
20
$6.19M
21
$5.68M
22
$5.58M
23
$5.47M
24
$4.84M
25
$4.56M